Cargando…

A validated nomogram integrating hematological indicators to predict response to neoadjuvant therapy in esophageal squamous cell carcinoma patients

BACKGROUND: The prognoses for advanced Esophageal squamous cell cancer (ESCC) was very poor. Neoadjuvant therapy was shown to improve overall survival of ESCC patients. However, there is still no effective indicator to predict the efficacy of neoadjuvant therapy. The present study intended to invest...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Sichao, Zhou, Zihao, Tian, Dan, Huang, Shujie, Wang, Ce, Gao, Zhen, Ben, Xiaosong, Tang, Jiming, Xie, Liang, Zhou, Haiyu, Zhang, Dongkun, Shi, Ruiqing, Deng, Cheng, Zhuang, Weitao, Ding, Yu, Qiao, Guibin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106100/ https://www.ncbi.nlm.nih.gov/pubmed/33987401 http://dx.doi.org/10.21037/atm-21-1628

Ejemplares similares

A novel prognostic model: which group of esophageal squamous cell carcinoma patients could benefit from adjuvant chemotherapy
por: Zhou, Zihao, et al.
Publicado: (2022)

Surgical resection of primary tumors improved the prognosis of patients with bone metastasis of non-small cell lung cancer: a population-based and propensity score-matched study
por: Tian, Dan, et al.
Publicado: (2021)

Optimal Range of Lymphadenectomy in Pathological Stage T1 and T2 Esophageal Squamous Cell Carcinoma
por: Wu, Hansheng, et al.
Publicado: (2021)

Accuracy of next-generation sequencing for molecular profiling of small specimen of lung cancer: a prospective pilot study of side-by-side comparison
por: Ben, Xiaosong, et al.
Publicado: (2022)

Factors influencing negative surgical outcomes in adult pectus excavatum patients undergoing Nuss procedure
por: Gao, Zhen, et al.
Publicado: (2021)

The staging performance of a modified tumor-node-metastasis staging system incorporated with lymphovascular invasion in patients with esophageal squamous cell carcinoma
por: Zhuang, Weitao, et al.
Publicado: (2022)

Discovery and validation of methylation signatures in circulating cell-free DNA for early detection of esophageal cancer: a case-control study
por: Qiao, Guibin, et al.
Publicado: (2021)

Conversion Surgery Following Immunochemotherapy in Initially Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma—A Real-World Multicenter Study (RICE-Retro)
por: Huang, Shujie, et al.
Publicado: (2022)

Dynamic alteration in SULmax predicts early pathological tumor response and short-term prognosis in non-small cell lung cancer treated with neoadjuvant immunochemotherapy
por: Sun, Taotao, et al.
Publicado: (2022)

Identification of a Ten-Gene Signature of DNA Damage Response Pathways with Prognostic Value in Esophageal Squamous Cell Carcinoma
por: Zhuang, Weitao, et al.
Publicado: (2021)

Mechanical factors play an important role in pectus excavatum with thoracic scoliosis
por: Wang, Yuncang, et al.
Publicado: (2012)

Does nivolumab combined with fluorouracil-based chemotherapy produce higher objective response rate than other immunochemotherapy regimes in metastatic esophageal cancer?: authors reply
por: Gao, Zhen, et al.
Publicado: (2023)

Efficacy and safety of immunochemotherapy, immunotherapy, chemotherapy, and targeted therapy as first-line treatment for advanced and metastatic esophageal cancer: a systematic review and network meta-analysis
por: Gao, Zhen, et al.
Publicado: (2023)

m(6)A-binding protein IGF2BP1 promotes the malignant phenotypes of lung adenocarcinoma
por: Wu, Hansheng, et al.
Publicado: (2022)

A nomogram based on hematological markers to predict radiosensitivity in patients with esophageal squamous cell carcinoma
por: Sun, Lijun, et al.
Publicado: (2023)

Clinical value of hematologic test in predicting tumor response to neoadjuvant chemotherapy with esophageal squamous cell carcinoma
por: Liu, Yinan, et al.
Publicado: (2014)

Should psychological distress be listed as a surgical indication for indeterminate pulmonary nodules: protocol for a prospective cohort study in real-world settings
por: Zhuang, Weitao, et al.
Publicado: (2022)

A Survival Prediction Nomogram for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgery
por: Ding, Tianyan, et al.
Publicado: (2021)

Predictive nomogram for postoperative atrial fibrillation in locally advanced esophageal squamous carcinoma cell with neoadjuvant treatment
por: Fang, Meiqin, et al.
Publicado: (2023)

Risk factors associated with prolonged viral clearance in patients with a refractory course of COVID-19: a retrospective study
por: Zhuang, Weitao, et al.
Publicado: (2021)

Prediction of Pathologic Response to Neoadjuvant Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma Incorporating Hematological Biomarkers
por: Wu, Yingjia, et al.
Publicado: (2021)

A prognostic nomogram that includes MPV in esophageal squamous cell carcinoma
por: He, Qiao, et al.
Publicado: (2023)

A prognostic nomogram for overall survival after neoadjuvant radiotherapy or chemoradiotherapy in thoracic esophageal squamous cell carcinoma: a retrospective analysis
por: Deng, Wei, et al.
Publicado: (2017)

A clinical nomogram for predicting tumor regression grade in esophageal squamous-cell carcinoma treated with immune neoadjuvant immunotherapy
por: Yu, Yongkui, et al.
Publicado: (2022)

A Nomogram for Predicting Lymphovascular Invasion in Superficial Esophageal Squamous Cell Carcinoma
por: Ruan, Rongwei, et al.
Publicado: (2021)

Pregnancy-associated lung cancer: a clinical and scientific challenge more than treatment dilemma
por: Zhuang, Weitao, et al.
Publicado: (2021)

DCE-MRI radiomics nomogram can predict response to neoadjuvant chemotherapy in esophageal cancer
por: Qu, Jinrong, et al.
Publicado: (2022)

Salivary microbiota may predict the presence of esophageal squamous cell carcinoma
por: Wei, Junmin, et al.
Publicado: (2021)

Predicting Prognosis and Adverse Events by Hematologic Markers in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy
por: Cai, Guoxin, et al.
Publicado: (2020)

Prognostic significance of tumor regression grade in esophageal squamous cell carcinoma after neoadjuvant chemoradiation
por: Zhang, Chi, et al.
Publicado: (2023)

A radiomics nomogram for predicting postoperative recurrence in esophageal squamous cell carcinoma
por: Tong, Yahan, et al.
Publicado: (2023)

Increases prognostic value of clinical-pathological nomogram in patients with esophageal squamous cell carcinoma
por: Hu, Jing Feng, et al.
Publicado: (2023)

Nomogram constructed by immunological and inflammatory indicators for predicting prognosis of patients with esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy plus surgery
por: Luo, Yun, et al.
Publicado: (2022)

Neoadjuvant immunotherapy for resectable esophagal squamous cell carcinoma: An ace up the sleeve
por: Zhou, Qing, et al.
Publicado: (2023)

COL19A1 is a predictive biomarker for the responsiveness of esophageal squamous cell carcinoma patients to immune checkpoint therapy
por: Liu, Jian‐Hua, et al.
Publicado: (2023)

Prognostic Nomogram for Thoracic Esophageal Squamous Cell Carcinoma after Radical Esophagectomy
por: Su, Dan, et al.
Publicado: (2015)

A Radiomics Nomogram for Non-Invasive Prediction of Progression-Free Survival in Esophageal Squamous Cell Carcinoma
por: Yan, Ting, et al.
Publicado: (2022)

Development and validation of a preoperative CT-based radiomic nomogram to predict pathology invasiveness in patients with a solitary pulmonary nodule: a machine learning approach, multicenter, diagnostic study
por: Huang, Luyu, et al.
Publicado: (2021)

CT-based deep learning radiomics and hematological biomarkers in the assessment of pathological complete response to neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma: A two-center study
por: Zhang, Meng, et al.
Publicado: (2023)

Construction and Evaluation of Nomogram for Hematological Indicators to Predict Pathological Response after Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
por: Wang, Keli, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6cpl4i34eb5djc4h64qa751cn1